Education Programme 2019 Summits

CBD and hemp extracts: exploring the potential

Wednesday 8th May, 15:20 - 17:20

The medicinal use of Cannabis is now legal in Europe, but what about CBD? Even though CBD as a substance is not considered a narcotic, there is great confusion about what is allowed in Europe regarding food use. For botanicals, the situation of CBD is far from being harmonised.

In our CBD summit we will look at the future opportunities for CBD in the food space as well as the current legal circumstances within Europe regarding this highly promising substance.

Chair: Joerg Gruenwald, United States Pharmacopoeia (USP) Committee for Botanical Dietary Supplements and Herbal Medicines

Sponsored by:

15:20 - 15:50

It is high time for CBD supplements in the EU?

  • The medicinal use of cannabis is now legal in Europe, but what about CBD in dietary supplements?
  • Reviewing the consequences of updated Novel Food catalogue entry for CBD and hemp
  • Outlining the future perspective on the use of this highly promising substance

Speaker: Dr Heike Stier, Senior Consultant, analyze & realize GmbH, (Germany) 

15:50 - 16:20

Food products derived from Cannabis sativa L: what’s the current state of play?

  • Outlining the current state of play regarding cannabis derived products and what's new?
  • Implications of change in legal framework on current practice
  • Guidance from Member States on enforcement regarding CBD food products and practical examples

Speaker: Karin Verzijden, Life Sciences Lawyer, Axon Lawyers (The Netherlands)

16:20 - 17:20

The GenCanna Production Platform

  • Building trust between consumers and hemp-derived CBD brands
  • Outlining the importance of consistency, compliance and chain of custody
  • Focusing on the importance of industry standards that will help shift CBD products into mainstream acceptance

Speaker: Garrett Bain, Chief Sales Officer, GenCanna Global USA (United States)

16:50 - 17:20

Secondary metabolites profiled in cannabis plant parts

  • Reviewing secondary metabolites profiling in cannabis inflorescence, leaf, stem bark, and root
  • Discussion on the presence of promising bio-active compounds
  • Potential to develop novel natural health products out of unused cannabis plant parts 

Speaker: Dan Jin, Analyst at Labs-Mart and PhD student, Biomedical Engineering Department, University of Alberta (Canada)